^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    LuCaFab (ITM-31)

    i
    Other names: ITM-31, CAXII-targeting 177Lu radiolabeled antibody Fab fragment, Lu-177 labeled 6A10-Fab-fragments, ITM 31, ITM31
    Associations

    News

    Trials
    Company:
    German Research Center for Environmental Health, ITM Isotopen Technologien Munchen
    Drug class:
    Beta radiation emitter, Carbonic anhydrase XII inhibitor
    Related drugs:
    Associations

    News

    Trials
    8ms
    RIT in GBM: Radioimmunotherapy with Lu-177 Labeled 6A10 Fab-fragments in Patients with Glioblastoma After Standard Treatment (clinicaltrials.gov)
    P1, N=15, Recruiting, University Hospital Muenster | Trial completion date: Jun 2025 --> Apr 2026 | Trial primary completion date: Jun 2025 --> Apr 2026
    Trial completion date • Trial primary completion date
    |
    LuCaFab (ITM-31)
    over2years
    RIT in GBM: Radioimmunotherapy With Lu-177 Labeled 6A10 Fab-fragments in Patients With Glioblastoma After Standard Treatment (clinicaltrials.gov)
    P1, N=15, Recruiting, University Hospital Muenster | Initiation date: Oct 2022 --> Jun 2023
    Trial initiation date
    |
    LuCaFab (ITM-31)